MBA at KSOM Bhubaneswar Offline Course

The candidate must be a graduate in any discipline with minimum 50% aggregate marks (or equivalent CGPA) from any university incorporated by an Act of the Central or State legislature in India or other educational institutions established by an Act of Parliament or declared to be deemed as a University under Section 3 of UGC Act, 1956, or possess an equivalent qualification recognized by the Ministry of HRD, Government of India. The candidate must have also minimum 50% aggregate marks (or equivalent CGPA) in the 10th and 12th board examinations. Candidates those who are awarded CGPA or grades in place of marks, their CGPA will be converted into equivalent marks based on the equivalence certified by the university/institution/board from where they obtained their degree/certificate. In absence of any instruction from the university, equivalence would be established by dividing obtained CGPA with the maximum CGPA and multiplying the fraction so obtained by 100. The percentage of aggregate marks is to be calculated taking all subjects into consideration including optional subjects. The candidate also requires to have a valid score of any national entrance examination for MBA or PGDM (e.g., CAT, XAT, CMAT, MAT, GMAT, KIITEE Management & KIITEE 2026, etc.).

Candidates appearing for the final examination for the Bachelor’s degree (or equivalent examination) and expected to complete all the requirements for obtaining the Bachelor’s degree by 30th June, 2026 can also apply, subject to submission of all the required documents to that effect by 30th September, 2026. Failing to submit the requisite documents in time will entitle a student to withdraw from the programme.

Foreign/NRI candidates will have the above eligibility for applying for the MBA programme and they are required to submit the filled-up application form along with the requisite documents and application fee of US $50. They will be considered for admission process on the basis of their valid GMAT scores (appeared in year 2025).